Clinical Trials in Xi'an, Shannxi

36 recruiting

Showing 120 of 32 trials

Recruiting
Phase 3

IBI363 vs Docetaxel in Patients With Advanced Squamous Lung Cancer After Standard Treatments Have Failed

iO Resistant sqNSCLC
Fortvita Biologics (USA)Inc.600 enrolled44 locationsNCT07217301
Recruiting
Not Applicable

Single-operator Versus Two-operator Technique in Single-balloon Enteroscopy

Single-balloon EnteroscopyOperation
Shuhui Liang206 enrolled6 locationsNCT06280469
Recruiting
Not Applicable

Frequency of Electrical Acupoint Stimulation on Hypotension in TAVR Patients

Transcatheter Aortic Valve Replacement (TAVR)Anesthesia Inductionhemodynamic stability+1 more
Air Force Military Medical University, China150 enrolled1 locationNCT07365345
Recruiting
Phase 2

Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.134 enrolled32 locationsNCT06897579
Recruiting
Not Applicable

Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions

Coronary Artery DiseaseDe Novo Stenosis
Xijing Hospital2,000 enrolled1 locationNCT07022587
Recruiting
Phase 1Phase 2

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Esophageal Squamous Cell CarcinomaNeoadjuvantIvonescimab
Tang-Du Hospital45 enrolled1 locationNCT07385001
Recruiting
Phase 1Phase 2

Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma

Diffuse Large B Cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.90 enrolled25 locationsNCT06829771
Recruiting
Phase 2

Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease

Coronary Artery Disease
Xijing Hospital18 enrolled1 locationNCT06572267
Recruiting

Study on the Preferences for PCI Implantation Devices Among Doctors and Patients

Coronary Artery DiseasePercutaneous Coronary Intervention
Xijing Hospital600 enrolled1 locationNCT07378163
Recruiting
Phase 2

Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy

SCLC,Extensive Stage
Tang-Du Hospital32 enrolled1 locationNCT07141264
Recruiting
Not Applicable

Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases (ACT-AD)

Alzheimer DiseaseTranscranial Magnetic StimulationCerebellum
Xijing Hospital100 enrolled4 locationsNCT06669182
Recruiting
Not Applicable

Repetitive Transcranial Magnetic Stimulation and Postoperative Neurocognitive Recovery

Postoperative Neurocognitive DisorderCognitive ImpairmentOlder Patients+2 more
Peking University First Hospital568 enrolled3 locationsNCT06482749
Recruiting

Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds

Ischemic Stroke
Xijing Hospital3,000 enrolled16 locationsNCT05032053
Recruiting
Phase 2

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

Breast Cancer
Xijing Hospital27 enrolled2 locationsNCT06914440
Recruiting
Not Applicable

Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis

Meniscus DisorderOsteoarthritis Knees BothPlatelets-rich Plasma+1 more
Xijing Hospital300 enrolled1 locationNCT06082531
Recruiting
Not Applicable

LAAO Versus NOAC in Patients with AF and PCI

Atrial FibrillationPercutaneous Coronary Intervention
Xijing Hospital1,386 enrolled1 locationNCT05353140
Recruiting
Not Applicable

The Safety and Efficacy Evaluation of Echocardiography-guided Percutaneous Radiofrequency Ablation for Cardiac Tumors: a Single-arm, Prospective, Single-center Clinical Study

Heart Neoplasms
Xijing Hospital40 enrolled1 locationNCT06830512
Recruiting
Phase 2

A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease

Chronic Graft Versus Host Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.52 enrolled12 locationsNCT06300320
Recruiting
Phase 2

Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study

Esophageal Cancer
Tang-Du Hospital80 enrolled1 locationNCT06663059
Recruiting
Not Applicable

Transcranial Electrical Stimulation Targeting the Cerebellum for the Treatment of Refractory Temporal Lobe Epilepsy

Magnetic Resonance ImagingTemporal Lobe EpilepsyElectroencephalogram+1 more
Xijing Hospital60 enrolled1 locationNCT06558890